penicillamine has been researched along with nifedipine in 17 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (11.76) | 18.7374 |
| 1990's | 6 (35.29) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 5 (29.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V | 1 |
| Barber, J; Dawson, S; Kenna, JG; Paul, N; Stahl, S | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Barr, WG | 1 |
| Grisanti, M; Vicencio, M | 1 |
| Connolly, SM | 1 |
| Tepperman, BL; Tripp, MA | 1 |
| Bergemann, A; Tikly, M | 1 |
| He, Q; Leitch, GJ; Visvesvara, GS; Wallace, S | 1 |
| Brenner, S; Ruocco, V | 1 |
| Bolotina, VM; Cohen, RA; Mongayt, DA; Zakharov, SI | 1 |
| Berkels, R; Hass, U; Klaus, W | 1 |
| Elston, DM | 1 |
3 review(s) available for penicillamine and nifedipine
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Current topics in the diagnosis and treatment of scleroderma.
Topics: Adult; Female; Humans; Nifedipine; Penicillamine; Scleroderma, Systemic | 1991 |
Scleroderma: therapeutic options.
Topics: Alprostadil; Captopril; Colchicine; Griseofulvin; Humans; Immunosuppressive Agents; Nifedipine; Penicillamine; Phenytoin; Physical Therapy Modalities; Plasmapheresis; Prostaglandins E; Scleroderma, Systemic; Vasodilator Agents | 1984 |
14 other study(ies) available for penicillamine and nifedipine
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
FDA-approved drug labeling for the study of drug-induced liver injury.
Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration | 2011 |
In vitro inhibition of the bile salt export pump correlates with risk of cholestatic drug-induced liver injury in humans.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Cholestasis; Drug-Related Side Effects and Adverse Reactions; Humans; Insecta; Rats; Risk Factors | 2012 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
[Pulmonary involvement in progressive systemic sclerosis].
Topics: Humans; Hypertension, Pulmonary; Lung Diseases; Nifedipine; Penicillamine; Pulmonary Fibrosis; Scleroderma, Systemic | 1986 |
Role of calcium in nitric oxide-mediated injury to rat gastric mucosal cells.
Topics: Alkaloids; Animals; Arginine; Calcium; Calcium Channel Blockers; Cell Survival; Chelating Agents; Dexamethasone; Egtazic Acid; Enzyme Inhibitors; Gastric Mucosa; Lanthanum; Male; NG-Nitroarginine Methyl Ester; Nifedipine; Nitric Oxide; Nitric Oxide Synthase; Penicillamine; Protein Kinase C; Rats; Rats, Sprague-Dawley; S-Nitroso-N-Acetylpenicillamine; Staurosporine | 1996 |
Cystic lung disease in systemic sclerosis: a case report with high resolution computed tomography findings.
Topics: Adult; Antirheumatic Agents; Cysts; Female; Humans; Lung Diseases; Nifedipine; Penicillamine; Pulmonary Fibrosis; Scleroderma, Systemic; Tomography, X-Ray Computed | 1996 |
Effects of nifedipine, metronidazole, and nitric oxide donors on spore germination and cell culture infection of the microsporidia Encephalitozoon hellem and Encephalitozoon intestinalis.
Topics: Acquired Immunodeficiency Syndrome; Animals; Antitrichomonal Agents; Calcium Channel Blockers; Cells, Cultured; Chlorocebus aethiops; Encephalitozoon; Encephalitozoonosis; Humans; Metronidazole; Nifedipine; Nitric Oxide; Nitroprusside; Penicillamine; S-Nitroso-N-Acetylpenicillamine; Spores | 1996 |
D-penicillamine-induced pemphigus foliaceus with autoantibodies to desmoglein-1.
Topics: Antirheumatic Agents; Autoantibodies; Autoantigens; Cadherins; Desmoglein 1; Drug Interactions; Female; Humans; Nifedipine; Pemphigus; Penicillamine; Vasodilator Agents | 1998 |
Monovalent cation and L-type Ca2+ channels participate in calcium paradox-like phenomenon in rabbit aortic smooth muscle cells.
Topics: 4-Aminopyridine; Animals; Aorta; Calcium; Calcium Channel Blockers; Calcium Channels; Calcium Channels, L-Type; Cations, Monovalent; Cesium; Chelating Agents; Egtazic Acid; Glutamine; Imidazoles; Lithium; Magnesium; Membrane Potentials; Muscle, Smooth, Vascular; Nifedipine; Patch-Clamp Techniques; Penicillamine; Potassium; Rabbits; Sodium; Tetraethylammonium; Vasoconstriction | 1999 |
The calcium antagonist nifedipine inhibits the uptake of acetylated LDL into endothelial cells.
Topics: Acetylation; Animals; Calcium Channel Blockers; Cells, Cultured; Cholesterol, LDL; Cyclic GMP; Cyclic GMP-Dependent Protein Kinases; Endothelium, Vascular; Enzyme Inhibitors; Nifedipine; Nitric Oxide; Nitric Oxide Donors; Penicillamine; S-Nitroso-N-Acetylpenicillamine; Swine | 2000 |
Photo quiz. Drug-induced pemphigus foliaceus.
Topics: Angiotensin-Converting Enzyme Inhibitors; Anti-Bacterial Agents; Anti-Inflammatory Agents, Non-Steroidal; Antirheumatic Agents; Arthritis; Azathioprine; Calcium Channel Blockers; Drug-Related Side Effects and Adverse Reactions; Humans; Immunosuppressive Agents; Minocycline; Mycophenolic Acid; Nifedipine; Pemphigus; Penicillamine; Skin | 2000 |